查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1325087

微流體裝置系統的全球市場

Microfluidic Device Systems
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 214 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球微流控設備系統市場將達到 188 億美元

在COVID-19之後的商業環境發生變化的情況下，微流控裝置系統的全球市場預計2022年為45億美元，預計到2030年將達到188億美元，2022年至2030年的年複合成長率預計將以19.5%的速度成長。體外診斷是本報告分析的細分市場之一，預計年複合成長率為 19.5%，到分析期結束時將達到 119 億美元。鑑於疫情后的持續復甦，製藥行業未來八年的年複合成長率已調整至 16.9%。

美國市場預計14億美元，中國預計年複合成長率19%

到 2022 年，美國微流體裝置系統市場預計將達到 14 億美元。中國作為世界第二大經濟體，預計到2030年市場規模將達到33億美元，2022年至2030年的分析期間年複合成長率為19%。其他值得注意的地域市場包括日本和加拿大，預計 2022 年至 2030 年將分別成長 17.5% 和 16.3%。在歐洲，德國的年複合成長率預計約為 13.4%。

受訪企業示例

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson & Company
  • Bio-Rad Laboratories, Inc.
  • Cepheid, Inc.
  • Dolomite Microfluidics
  • Fluidigm Corporation
  • Johnson & Johnson
  • Micronit Microtechnologies BV
  • RainDance Technologies, Inc.
  • Roche Diagnostics（Schweiz）AG
  • Siemens Healthineers

目錄

第1章 調查方法

第2章 執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場預測

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 世界其他地區

第4章 競爭

簡介目錄
Product Code: MCP16590

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Microfluidic Device Systems Market to Reach $18.8 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Microfluidic Device Systems estimated at US$4.5 Billion in the year 2022, is projected to reach a revised size of US$18.8 Billion by 2030, growing at aCAGR of 19.5% over the period 2022-2030. In-vitro Diagnostics, one of the segments analyzed in the report, is projected to record 19.5% CAGR and reach US$11.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Pharmaceuticals segment is readjusted to a revised 16.9% CAGR for the next 8-year period.

The U.S. Market is Estimated at $1.4 Billion, While China is Forecast to Grow at 19% CAGR

The Microfluidic Device Systems market in the U.S. is estimated at US$1.4 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.3 Billion by the year 2030 trailing a CAGR of 19% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 17.5% and 16.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 13.4% CAGR.

Select Competitors (Total 23 Featured) -

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson & Company
  • Bio-Rad Laboratories, Inc.
  • Cepheid, Inc.
  • Dolomite Microfluidics
  • Fluidigm Corporation
  • Johnson & Johnson
  • Micronit Microtechnologies B.V.
  • RainDance Technologies, Inc.
  • Roche Diagnostics (Schweiz) AG
  • Siemens Healthineers

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Microfluidic Device Systems - Global Key Competitors Percentage Market Share in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Microfluidic Device Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Microfluidic Device Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Microfluidic Device Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for In-vitro diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for In-vitro diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for In-vitro diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for Medical Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Point of care testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Point of care testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 15: World 16-Year Perspective for Point of care testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Pharmaceutical and life science research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Pharmaceutical and life science research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 18: World 16-Year Perspective for Pharmaceutical and life science research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Drug delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Drug delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 21: World 16-Year Perspective for Drug delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Analytical devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Analytical devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 24: World 16-Year Perspective for Analytical devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Clinical and veterinary diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Clinical and veterinary diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 27: World 16-Year Perspective for Clinical and veterinary diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Environment and Industrial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Environment and Industrial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 30: World 16-Year Perspective for Environment and Industrial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 31: World Microfluidic Device Systems Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Microfluidic Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2014, 2023 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2014, 2023 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2014, 2023 & 2030
  • JAPAN
    • Microfluidic Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2014, 2023 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2014, 2023 & 2030
  • CHINA
    • Microfluidic Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 52: China 16-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2014, 2023 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 55: China 16-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2014, 2023 & 2030
  • EUROPE
    • Microfluidic Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Microfluidic Device Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Microfluidic Device Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Microfluidic Device Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2014, 2023 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2014, 2023 & 2030
  • FRANCE
    • Microfluidic Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 65: France Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 67: France 16-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2014, 2023 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 70: France 16-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2014, 2023 & 2030
  • GERMANY
    • Microfluidic Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2014, 2023 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2014, 2023 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Microfluidic Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 83: UK Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2014, 2023 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 88: UK 16-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2014, 2023 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Microfluidic Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2014, 2023 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2014, 2023 & 2030
  • REST OF WORLD
    • TABLE 101: Rest of World Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 102: Rest of World Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 103: Rest of World 16-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2014, 2023 & 2030
    • TABLE 104: Rest of World Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Rest of World Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 106: Rest of World 16-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2014, 2023 & 2030

IV. COMPETITION